NX Development Corp.
Louisville
About NX Development Corp.
Upon conducting research with leaders in the field, it is clear that an ideal solution for neurosurgeons approaching removal of Glioblastoma is a procedure which: increases the precision and extent of tumor resection, has a manageable capital equipment cost for the hospital and has appropriate cost-benefit characteristics to the payers and does not introduce new medical risk factors - the use of Gliolan™ in conjunction with existing and growing installed base of fluorescence add-on kits manufactured by the two leading surgical microscope manufacturers provides just such a solution.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: M&A
- Last round: Series Unknown (May 2016)
- Website: nxdevcorp.com
- Phone: (305)929-3125
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nx-development-corp-95349 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.